2 cell type differentiation (pale ductal and dark basaloid)
Nuclear pleomorphism (at high magnification)
Uniform small hyperchromatic nuclei
Frequent mitotic figures
Mitotic figures infrequent
p63 diffuse positivity and smooth muscle actin usually negative
p63 and smooth muscle actin clearly define a surrounding myoepithelial component
Perineural invasion infrequent
Perineural invasion common
Grading / Staging
Grading
No widely accepted well described, tested grading scheme
WHO recommendation
Well differentiated – Large squamous differentiating cells predominate over small basaloid cells
Poorly differentiated - Small basaloid cells predominate over large squamous differentiating cells
Moderately differentiated – Intermediate mixtures, should make up about 2/3 of cases
Undifferentiated
Grading based on differentiation and cytologic features is not a good predictor of behavior
Following scheme has been proposed as predictive of 5 year survival (Sarbia 1995)
Points are allocated as indicated in the table
1
2
3
4
Pattern of invasion
Pushing, well defined margins
Infiltrating solid cords and bands
Small groups of dissociated cells
Marked cellular discohesion
Inflammatory response
Marked
Moderate
Slight
None
Cases are then stratified based on the sum of the two scores
Group I – 2 or 3 points
Group II – 4 points
Group III – 5 or 6 points
Group IV – 7 or 8 points
If the complete scheme is not used, it is probably worthwhile to comment on the pattern of invasion and inflammatory response
Staging
Same TNM for esophageal squamous and adenocarcinomas
Bibliography
Bosman FT, Carneiro F, Hruban RH, Thiese ND (Eds). WHO Classifiication of Tumors of the Digestive System, IARC, Lyon 2010
Sarbia M, Becker KF, Höfler H. Pathology of upper gastrointestinal malignancies. Semin Oncol. 2004 Aug;31(4):465-75.
Iwaya T, Maesawa C, Tamura G, Sato N, Ikeda K, Sasaki A, Othuka K, Ishida K, Saito K, Satodate R. Esophageal carcinosarcoma: a genetic analysis. Gastroenterology. 1997 Sep;113(3):973-7.
Wang ZY, Itabashi M, Hirota T, Watanabe H, Kato H. Immunohistochemical study of the histogenesis of esophageal carcinosarcoma. Jpn J Clin Oncol. 1992 Dec;22(6):377-86.
Iyomasa S, Kato H, Tachimori Y, Watanabe H, Yamaguchi H, Itabashi M. Carcinosarcoma of the esophagus: a twenty-case study. Jpn J Clin Oncol. 1990 Mar;20(1):99-106.
Guarino M, Reale D, Micoli G, Forloni B. Carcinosarcoma of the oesophagus with rhabdomyoblastic differentiation. Histopathology. 1993 May;22(5):493-8.
Osborn NK, Keate RF, Trastek VF, Nguyen CC. Verrucous carcinoma of the esophagus: clinicopathophysiologic features and treatment of a rare entity. Dig Dis Sci. 2003 Mar;48(3):465-74.
Sarbia M, Bittinger F, Porschen R, Dutkowski P, Willers R, Gabbert HE. Prognostic value of histopathologic parameters of esophageal squamous cell carcinoma. Cancer. 1995 Sep 15;76(6):922-7.
Sarbia M, Verreet P, Bittinger F, Dutkowski P, Heep H, Willers R, Gabbert HE. Basaloid squamous cell carcinoma of the esophagus: diagnosis and prognosis. Cancer. 1997 May 15;79(10):1871-8.
Tsang WY, Chan JK, Lee KC, Leung AK, Fu YT. Basaloid-squamous carcinoma of the upper aerodigestive tract and so-called adenoid cystic carcinoma of the oesophagus: the same tumour type? Histopathology. 1991 Jul;19(1):35-46.
Li TJ, Zhang YX, Wen J, Cowan DF, Hart J, Xiao SY. Basaloid squamous cell carcinoma of the esophagus with or without adenoid cystic features. Arch Pathol Lab Med. 2004 Oct;128(10):1124-30.